# Reflect Scientific, Inc.: Form 10-Q for the period ended Jun 30, 2015

- Company: [Reflect Scientific, Inc.](/companies/rscf.md) (CIK 1103090)
- Form: 10-Q
- Filed: 2015-08-07
- Accepted by EDGAR: Aug 7, 2015, 17:13 ET
- Period: 2015-06-30
- Accession: 0001548123-15-000272
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1103090/000154812315000272/f10qq215v5.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1103090/000154812315000272/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-04-01 to 2015-06-30 | $198.1k | us-gaap:Revenues |
| Revenue | 6 months, 2015-01-01 to 2015-06-30 | $511.3k | us-gaap:Revenues |
| Cost of revenue | 3 months, 2015-04-01 to 2015-06-30 | $56.3k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2015-01-01 to 2015-06-30 | $177.7k | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-04-01 to 2015-06-30 | $141.7k | us-gaap:GrossProfit |
| Gross profit | 6 months, 2015-01-01 to 2015-06-30 | $333.6k | us-gaap:GrossProfit |
| Research and development | 3 months, 2015-04-01 to 2015-06-30 | $20.9k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2015-01-01 to 2015-06-30 | $26.1k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2015-04-01 to 2015-06-30 | −$47.9k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2015-01-01 to 2015-06-30 | −$49.6k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-04-01 to 2015-06-30 | −$263 | us-gaap:InterestExpense |
| Interest expense | 6 months, 2015-01-01 to 2015-06-30 | −$566 | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-04-01 to 2015-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2015-01-01 to 2015-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-04-01 to 2015-06-30 | $1.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2015-01-01 to 2015-06-30 | $1.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2015-01-01 to 2015-06-30 | $0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Cash and equivalents | at 2015-06-30 | $309.7k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-06-30 | $646.8k | us-gaap:AssetsCurrent |
| Total assets | at 2015-06-30 | $727.9k | us-gaap:Assets |
| Current liabilities | at 2015-06-30 | $47.6k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-06-30 | $47.6k | us-gaap:Liabilities |
| Shareholders' equity | at 2015-06-30 | $680.2k | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 11,267 characters.

#### Special Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by or on behalf of our Company. Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Annual Report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance, however, that management’s expectations will necessarily come to pass. Factors that may affect forward- looking statements include a wide range of factors that could materially affect future developments and performance, including the following:

Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest;

Changes in U.S., global or regional economic conditions;

Changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments;

Increased competitive pressures, both domestically and internationally;

Legal and regulatory developments, such as regulatory actions affecting environmental activities;

The imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls;

Adverse weather conditions or natural disasters, such as hurricanes and earthquakes, labor disputes, which may lead to increased costs or disruption of operations.

This list of factors that may affect future performance and the accuracy of forward-looking statements are illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

#### Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited Financial Statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions. The Company believes there have been no significant changes during the three and six month periods ended June 30, 2015, to the items disclosed as significant accounting policies in management's Notes to the Financial Statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2014.

#### Plan of Operation and Business Growth

Our efforts continue to be focused on increasing the sales of our life science consumables and detectors while, at the same time, working to commercialize our liquid nitrogen refrigeration products. Of those liquid nitrogen refrigeration products, the refrigerated trailer, known as a “reefer”, is receiving highest priority. We have our first manufactured unit operational, have conducted a number of road tests and are working to develop alliances with contract manufacturers for those products.

We also continue to focus on the expansion of our detector. We believe that the enhanced functionality of our new detector, coupled with its low cost, provides us with a competitive edge over products currently being sold in that specialized market.

Concurrent with the development and commercialization of the above products, we have completed our on-line catalog and are making progress in enrolling new distributors for our consumable products.

Our revenues during the three and six month reporting periods decreased 47% and 34%, respectively during 2015 compared to 2014 revenues.

#### Results of Operations

#### Three Months Ended June 30, 2015 and 2014

|  | For the three months ended June 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: |
| Revenues | $198,076 | $378,913 | $(180,837) |
| Cost of goods sold | 56,349 | 167,466 | (111,117) |
| Gross profit | 141,727 | 211,447 | (69,720) |
| Operating expenses | 189,579 | 200,572 | (10,993) |
| Other income (expense) | 1,325,862 | (30,237) | 1,295,625 |
| Net income (loss) | $1,278,010 | $(19,362) | $1,258,648 |

Revenues decreased during the quarter ended June 30, 2015, to $198,076 from $378,913 for the quarter ended June 30, 2014, a decrease of $180,837. The decline in revenues seen during the quarter resulted from the acquisition of a major customer by another firm, disrupting the normal flow of orders we generally receive from that client. All of the revenues generated during the three month period ended June 30, 2015 were from our specialized laboratory supplies and detector sales. We are continuing work to refine and commercialize the ultra-low temperature freezer technologies, and have received orders for additional units for delivery early 4th quarter.

With decreased sales during the reporting period, cost of goods correspondingly decreased in the quarter ending June 30, 2015, as compared to June 30, 2014 to $56,349 from $167,466, a increase of $111,117. The gross profit percentage increased to 72% for the three months ended June 30, 2015, compared to 56% for the three months ended June 30, 2014. The gross profit percentage is dependent on the mix of product sales, which varies from quarter to quarter. We continue to actively work to obtain more favorable pricing from our vendors in order to increase the margins realized on our product lines.

As a result of our continued focus on operating expenses we realized a reduction of operating expenses in the current period. This reduction is the result of cost reduction efforts implemented by management and an ongoing quest to gain additional operating efficiencies. Operating expenses for the three months ended June 30, 2014 were $189,579, which represents a decrease of $10,993 from the $200,572 in operating expenses recorded for the three month period ended June 30, 2014. The decrease results primarily from a reduction in our bad debt provision, offset in part by small increases in a number of expense categories. Operating expenses for the remaining six months of 2015 are expected to approximate the expense levels shown for the three month period ended June 30, 2015.

The net income for the three month period ended June 30, 2015 was $1,278,010, an improvement of $1,258,648 from the $19,362 loss for the three month period ended June 30, 2014. Management continues to look for opportunities to increase sales, improve gross margins and reduce ongoing operating expenses

The net income for the three months ended June 30, 2015 was $0.02 per share. This compares to a net loss of $0.01 per share for the three month period ended June 30, 2014.

#### Six Months Ended June 30, 2015 and 2014

|  | For the six months ended June 30, 2015 | 2014 | Change |
| --- | ---: | ---: | ---: |
| Revenues | $511,298 | $781,355 | $(270,057) |
| Cost of goods sold | 177,666 | 331,249 | (153,583) |
| Gross profit | 333,632 | 450,106 | (116,474) |
| Operating expenses | 383,207 | 382,054 | 1,153 |
| Other income (expense) | 1,296,309 | (61,320) | 1,357,630 |
| Net profit (loss) | $1,246,734 | $6,732 | $1,240,002 |

Revenues decreased during the six month period ended June 30, 2015, to $511,298 from $781,355 for the six month period ended June 30, 2014, a decrease of $270,057. All of the revenues were generated from our specialized laboratory supplies and detector sales, as we work to continue to refine and commercialize the ultra low temperature freezer technologies. We completed our catalog web site and have distributed our catalog to a number of potential new distributors. We have brought on additional distributors to expand the distribution channels for our products.

Due to the decrease in sales, cost of goods in the six month period ending June 30, 2015 decreased by $153,583, to $177,666 from $331,249 for the six month period ended June 30, 2014. The gross profit percentage increased to 65% for the six month period ended June 30, 2015, compared to 58% for the six months ended June 30, 2014. The gross profit percentage is dependent on the mix of product sales, which varies from quarter to quarter. We continue to actively work to obtain more favorable pricing from our vendors in order to increase the margins realized on our product lines.

Continued focus to control operating expenses resulted in an increase of only $1,153 in the current six month period. This increase results from slightly higher expenses levels for a number of expense categories, offset by a favorable adjustment to the bad debt allowance. Operating expenses for the six months ended June 30, 2015 were $383,207, compared to $382,054 shown for the six month period ended June 30, 2014.

Net income for the six month period ended June 30, 2015 was $1,246,734, a $1,240,002 improvement from the $6,732 net income for the six month period ended June 30, 2014. Management continues to look for opportunities to increase revenue, improve gross margins and reduce ongoing operating expenses in order to achieve profitability.

Earnings for the six months ended June 30, 2015 was $0.02 per share. Earnings for the six months ended June 30, 2014 was $0.00 per share.

#### Seasonality and Cyclicality

We do not believe our business is cyclical.

#### Liquidity and Capital Resources

Our cash resources at June 30, 2015, were $309,733, with accounts receivable of $93,741, net of allowance, and inventory of $240,179, net of allowance. To this time we have relied on revenues and sales of equity and debt securities for our cash resources. Our working capital on June 30, 2015, was $599,105. Working capital on December 31, 2014 was a deficit of $663,672, due primarily to the $650,000 in defaulted debentures and $646,875 in accrued interest related to those debentures.

For the six month period ended June 30, 2015, net cash provided from operating activities was $43,965 which compares to $120,607 net cash provided from operating activities for the six month period ended June 30, 2014.

### Off-Balance Sheet Arrangements

We lease office and warehouse space under a non-cancelable operating lease in Utah which runs through November 30, 2017. Future minimum lease payments under the operating lease at June 30, 2015 are $89,900 for that facility. In addition, on May 9, 2014, the Company entered into an automobile lease. Future minimum lease payments under this lease are $15,600 at June 30, 2015, with minimum lease payments of $3,744 due for the remainder of 2015, $7,488 in 2016, and $4,368 in 2017.

## Market risk

As filed, 349 characters.

In June 2015, management received from legal counsel an opinion that the statute of limitations had expired on the debentures and the related default penalty and accrued interest. Accordingly, management elected to remove those liabilities from their financial records, resulting in the recognition of a gain on extinguishment of debt of $1,355,375.

## Controls and procedures

As filed, 2,088 characters.

### (a)

### Evaluation of Disclosure Controls and Procedures.

As of the end of the period covered by this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon this evaluation, our Chief Executive Officer and Principal Financial Officer concluded that information required to be disclosed is recorded, processed, summarized and reported within the specified periods, and is accumulated and communicated to management, including our Chief Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure of material information required to be included in our periodic Securities and Exchange Commission reports. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures are not effective at that reasonable assurance level as of the end of the period covered by this report based upon our current level of transactions and staff. However, it should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

### (b)

### Changes in Internal Control Over Financial Reporting.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act. Management reviewed our internal controls over financial reporting, and there have been no changes in our internal controls over financial reporting for the quarter ended June 30, 2014 that have materially affected, or are likely to affect, our internal controls over financial reporting.

Filed Aug 7, 2015.
Source: SEC EDGAR, the filing index for accession 0001548123-15-000272. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.
